Northrook, IL -- (SBWIRE) -- 10/21/2019 -- [129 Pages Report] Medical Membranes Market was valued at USD 1.95 Billion in 2016 and is projected to reach USD 3.31 Billion by 2022, at a CAGR of 9.2% from 2017 to 2022. The growth of the medical membranes market can be attributed to the increasing demand for high-purity selective separation, expanding healthcare and pharmaceutical industries, and increasing number of End-Stage Renal Disease (ESRD) patients. The base year considered for the study is 2016, while the forecast period is from 2017 to 2022.

Download PDF brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86

Growing healthcare and pharmaceutical industry

The healthcare industry is flourishing in all regions, especially in the developing regions of APAC, the Middle East & Africa, and South America. The growth is driven by growing population and aging population.

Many governments are taking different initiatives to cut costs and improve the quality of their healthcare infrastructure. Improving healthcare facilities will fuel the growth of the healthcare market globally. Growth in the healthcare facilities will increase the demand for medical products and will drive the demand for medical membranes.

The home healthcare industry is on the rise with the growing older population. In the US, the majority of the population over 65 years is receiving home healthcare services. Approximately, 96% of this old-age population requires bathing assistance, and 88% requires assistance in transferring in and out of bed. In 2015, home healthcare expenditure reached USD 88.8 billion, from USD 83.6 billion in 2014. This growth is expected to continue in the near future. The rising healthcare costs, along with costs associated with hospital re-admissions, are making home care a feasible option.

The growing home healthcare industry has increased the demand for lightweight, disposable, and user-friendly devices. Many of these devices use membranes to maintain the purity standards. Home care and self-medication require disposable products as sterilization facilities are not available. These factors increase the demand for medical membranes.

Key Target Audience:
- Medical Membranes Manufacturing Companies
- Medical Membranes Distributors
- Raw Material Suppliers
- Medical Grade Polymer Formulators & Compounders
- Commercial Research & Development (R&D) Institutes
- Trade Associations and Government Agencies
- FDA Regulatory Bodies

Based on process technology, the medical membranes market has been segmented into ultrafiltration, microfiltration, nanofiltration, and others. The ultrafiltration process technology is projected to lead the medical membranes market from 2017 to 2022. The increasing use of ultrafiltration process technology in pharmaceutical filtration will help increase the market share of ultrafiltration in the medical membranes market.

Based on region, the medical membranes market has been segmented into APAC, North America, Europe, and the Rest of the World. Europe is the leading market for medical membranes. The growth of the medical membranes market in Europe is driven by the increasing aging population (above 65 years), growing End-Stage Renal Disease (ESRD) patient pool, increasing availability of improved diagnosis facilities, and rising incidences of chronic diseases, such as diabetes and hypertension.

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=86

Pall Corporation (US), Asahi Kasei (Japan), 3M (US), Sartorius (Germany), and Merck Millipore (US) are key companies operating in the medical membranes market. Other major manufacturers of medical membranes include GE Healthcare (US), Koch Membrane Systems (US), and W. L. Gore & Associates (US).

About MarketsandMarkets
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com